Cases
Forty Seven, Inc.
Merger
Overview
Overview
- Date:
- 3/2/2020
- Case Caption:
- Parr v. Forty Seven, Inc., et al.
- Stock Symbol:
- FTSV
- Company Name - Buyer:
- Gilead Sciences, Inc.
- Stock Symbol - Buyer:
- GILD
- Status:
- Closed/Complete
- Merger Announcement Date:
- 3/2/2020
- Court:
- U.S. District Court: Northern California
On March 2, 2020, Forty Seven announced that it had signed an agreement to merge with Gilead Sciences. Pursuant to the merger agreement, Forty Seven stockholders will receive $95.50 in cash for each share of Forty Seven common stock owned. The deal is scheduled to close in the second quarter of 2020.
Bragar Eagel & Squire is concerned that Forty Seven’s board of directors oversaw an unfair process and ultimately agreed to an inadequate deal price. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Forty Seven stockholders.
Bragar Eagel & Squire is concerned that Forty Seven’s board of directors oversaw an unfair process and ultimately agreed to an inadequate deal price. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Forty Seven stockholders.
Case Updates
Case Files
-
Parr v. Forty Seven, Inc., et al.
-
Parr v. Forty Seven, Inc., et al.